España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Brainstorm Cell
BCLI
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.82
-0.09
-4.71%
At close: -
$1.89
0.07
3.85%
After Hours: Jan 31, 6:34 AM EDT
Get Report
Comment
Brainstorm Cell (BCLI) Forecast
News
Earnings
Brainstorm Cell (BCLI) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Brainstorm Cell (NASDAQ:BCLI) Stock
Brainstorm Cell Stock (NASDAQ: BCLI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 03, 2024
BrainStorm Receives Notice Of Allowance fFr U...
Benzinga Newsdesk
Thursday, November 14, 2024
Brainstorm Cell Q3 2024 GAAP EPS $(0.51) Beat...
Benzinga Newsdesk
Monday, November 11, 2024
Brainstorm Cell Therapeutics and Pluri shares...
Benzinga Newsdesk
BrainStorm Enters Memorandum Of Understanding...
Benzinga Newsdesk
Wednesday, October 30, 2024
Brainstorm Cell Therapeutics Received Written...
Benzinga Newsdesk
Monday, October 28, 2024
BrainStorm Cell Therapeutics Announced The Pr...
Benzinga Newsdesk
Monday, October 07, 2024
Brainstorm Cell Therapeutics shares are tradi...
Benzinga Newsdesk
BrainStorm CEO to Discuss Phase 3b ALS Trial ...
Benzinga Newsdesk
Tuesday, October 01, 2024
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Monday, September 30, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Friday, September 27, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Tuesday, September 24, 2024
BrainStorm Cell Therapeutics Plans To Share L...
Benzinga Newsdesk
Wednesday, August 14, 2024
Brainstorm Cell Q2 2024 GAAP EPS $(0.04), Inl...
Benzinga Newsdesk
Wednesday, July 24, 2024
BrainStorm Cell Therapeutics Updates On NurOw...
Benzinga Newsdesk
Friday, July 19, 2024
BrainStorm Cell Therapeutics Says On July 18,...
Benzinga Newsdesk
Thursday, July 11, 2024
Maxim Group Upgrades Brainstorm Cell to Buy, ...
Benzinga Newsdesk
Thursday, June 27, 2024
BrainStorm Cell Therapeutics Prices $4.0M Reg...
Benzinga Newsdesk
Wednesday, June 26, 2024
BrainStorm Cell Therapeutics Reaches Alignmen...
Benzinga Newsdesk
Thursday, June 20, 2024
BrainStorm Cell Therapeutics Taps Haro Hartou...
Benzinga Newsdesk
Friday, June 14, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Monday, June 10, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, May 24, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Monday, May 20, 2024
BrainStorm Cell Therapeutics to Present New B...
Benzinga Newsdesk
Tuesday, May 14, 2024
Brainstorm Cell Q1 2024 Adj EPS $(0.05) Beats...
Benzinga Newsdesk
Monday, May 06, 2024
Brainstorm Cell Therapeutics shares are tradi...
Benzinga Newsdesk
Friday, May 03, 2024
Brainstorm Cell Therapeutics Received Letter ...
Benzinga Newsdesk
Tuesday, April 30, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Wednesday, April 17, 2024
Reported Earlier, BrainStorm Cell Therapeutic...
Benzinga Newsdesk
Thursday, April 11, 2024
BrainStorm Cell Therapeutics Regains Complian...
Benzinga Newsdesk
Wednesday, April 10, 2024
Brainstorm Cell Therapeutics Announced Peer-r...
Benzinga Newsdesk
Tuesday, April 09, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Brainstorm Cell Therapeutics Received Written...
Benzinga Newsdesk
Monday, April 01, 2024
Brainstorm Cell Q4 EPS $(0.11) Beats $(0.15) ...
Benzinga Newsdesk
Brainstorm Cell Therapeutics shares are tradi...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Brainstorm Cell: Q4 Earnings Insights
Benzinga Insights
BrainStorm Cell Therapeutics Reported FY23 EP...
Benzinga Newsdesk
Monday, March 25, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Wednesday, March 20, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Tuesday, March 05, 2024
Brainstorm Cell Therapeutics Has Been Granted...
Benzinga Newsdesk
Tuesday, February 27, 2024
Brainstorm Cell Therapeutics Will Present A P...
Benzinga Newsdesk
Friday, February 23, 2024
Brainstorm Cell Therapeutics Submits Special ...
Benzinga Newsdesk
Wednesday, February 21, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, February 19, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Tuesday, February 13, 2024
BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society (ORS) 2024 Annual Meeting
Faith Ashmore
-
Sponsored
Tuesday, January 30, 2024
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Monday, January 22, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, January 12, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Show More
